Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic heart failure (HF). These events are associated with poorer quality of life, increased risks of hospitalization and death and are a major burden on healthcare resources. They usually require diuretic therapy, either administered intravenously or by escalation of oral doses or with combinations of different diuretic classes. Additional treatments may also have a major role, including initiation of guideline-recommended medical therapy (GRMT). Hospital admission is often necessary but treatment in the emergency service or in outpatient clinics or by primary care physicians has become increasingly used. Prevention of first and recurring episodes ...
Heart failure (HF) is a clinical syndrome characterized by dyspnoea, fatigue and fluid retention acc...
Heart failure (HF) remains a major global problem. In the Netherlands, 1.5-2.0% of the total populat...
Novel pharmacologic treatment options reduce mortality and morbidity in a cost-effective manner in p...
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic h...
: Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
The ESC has published a series of guidelines on heart failure (HF) over the last 25 years, most rece...
Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart ...
The diagnosis of heart failure (HF) primarily relies on signs and symptoms that are neither sensitiv...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
In The Netherlands, the incidence and prevalence of heart failure are rising as is the case in most ...
Despite the availability of a number of different classes of therapeutic agents with proven efficacy...
Heart failure (HF) is a clinical syndrome characterized by dyspnoea, fatigue and fluid retention acc...
Heart failure (HF) remains a major global problem. In the Netherlands, 1.5-2.0% of the total populat...
Novel pharmacologic treatment options reduce mortality and morbidity in a cost-effective manner in p...
Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic h...
: Episodes of worsening symptoms and signs characterize the clinical course of patients with chronic...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
The ESC has published a series of guidelines on heart failure (HF) over the last 25 years, most rece...
Cardiomyopathies are a heterogeneous group of heart muscle diseases and an important cause of heart ...
The diagnosis of heart failure (HF) primarily relies on signs and symptoms that are neither sensitiv...
The European Society of Cardiology (ESC) has published a series of guidelines on heart failure (HF) ...
In The Netherlands, the incidence and prevalence of heart failure are rising as is the case in most ...
Despite the availability of a number of different classes of therapeutic agents with proven efficacy...
Heart failure (HF) is a clinical syndrome characterized by dyspnoea, fatigue and fluid retention acc...
Heart failure (HF) remains a major global problem. In the Netherlands, 1.5-2.0% of the total populat...
Novel pharmacologic treatment options reduce mortality and morbidity in a cost-effective manner in p...